There were no statistically significant differences in GLUT1 mRNA/protein expression between tumors with different demographic and clinicopathological parameters (age, tumor grade, tumoral size, lymph node metastasis, menopausal status, ER and PR status). Here, SLC2A1 is linked to metastatic malignant neoplasm in the lymph nodes.